AK Medical Holdings Limited (1789.HK)
HKD 4.76
(-1.65%)
HKD 4.76
(-1.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 33.93 Million | 242.91 Million | 176.62 Million | 205.25 Million | 144.66 Million | 127.99 Million |
| Net Income | 231.11 Million | 240.29 Million | 108.55 Million | 376.6 Million | 321.4 Million | 174.5 Million |
| Depreciation & Amortization | 90.93 Million | 80.4 Million | 74.15 Million | 60.52 Million | 32.15 Million | 20.74 Million |
| Deferred income taxes | - | - | -29.65 Million | -34.38 Million | -28.17 Million | - |
| Stock-based compensation | 5.05 Million | 8.12 Million | 1.05 Million | 1.99 Million | 10.69 Million | 4.98 Million |
| Change in working capital | -235.53 Million | -40.33 Million | 31.02 Million | -185.52 Million | -178.01 Million | -42.01 Million |
| Other non-cash items | -25.44 Million | -45.56 Million | -8.52 Million | -13.95 Million | -13.39 Million | -30.21 Million |
| Investing Cash Flow | -318.14 Million | -82.29 Million | -297.1 Million | -356.4 Million | -271.8 Million | -223.54 Million |
| Investments in PPE | -196.07 Million | -121.71 Million | -76.22 Million | -89.78 Million | -106.91 Million | -73.52 Million |
| Acquisitions | - | - | -3.41 Million | -261.03 Million | - | -123.79 Million |
| Investment purchases | -1.76 Billion | -1.92 Billion | -1.03 Billion | -547.9 Million | -180 Million | -35 Million |
| Sales/Maturities of investments | 1.62 Billion | 1.94 Billion | 802.69 Million | 528.32 Million | - | 2.84 Million |
| Other Investing Activities | 1.05 Million | 18.64 Million | 18.93 Million | 13.99 Million | 15.11 Million | 5.93 Million |
| Financing Cash Flow | -14.02 Million | -36.79 Million | -100.7 Million | 611.74 Million | -21.66 Million | -4.17 Million |
| Debt repayment | -53.54 Million | -10.71 Million | -12.78 Million | -1.7 Million | -5.18 Million | -471 Thousand |
| Dividends payments | -61.5 Million | -23.96 Million | -36.69 Million | -75.38 Million | -32.15 Million | -32.01 Million |
| Common Stock Repurchased | - | 10.71 Million | -49.83 Million | - | 5.18 Million | 471 Thousand |
| Common Stock Issuance | 8.93 Million | 57 Thousand | 222 Thousand | 712.65 Million | 14.64 Million | 56.58 Million |
| Other Financing Activities | 7.11 Million | -12.89 Million | -1.6 Million | -23.83 Million | -4.15 Million | -28.74 Million |
| Accounts receivables | 3.32 Million | -26.81 Million | 23.11 Million | -190.3 Million | -172.56 Million | -38.8 Million |
| Accounts payables | - | 26.81 Million | -23.11 Million | 190.3 Million | 172.56 Million | 38.8 Million |
| Inventory | -193.18 Million | 20.73 Million | -62.35 Million | -69.43 Million | -62.92 Million | -37.32 Million |
| Other working capital | -70.88 Million | -61.07 Million | 93.38 Million | -116.09 Million | -115.09 Million | -4.69 Million |
| Cash at beginning of period | 625.82 Million | 475.6 Million | 713.09 Million | 276.52 Million | 421.05 Million | 517.48 Million |
| Cash at end of period | 331.21 Million | 625.82 Million | 475.6 Million | 713.09 Million | 276.52 Million | 421.05 Million |
| Capital Expenditure | -196.07 Million | -121.71 Million | -76.22 Million | -89.78 Million | -106.91 Million | -73.52 Million |
| Effect of forex changes on cash | 3.62 Million | 26.39 Million | -16.3 Million | -24.01 Million | 4.27 Million | 3.3 Million |
| Net cash flow / Change in cash | -294.61 Million | 150.22 Million | -237.48 Million | 436.57 Million | -144.53 Million | -96.42 Million |
| Free Cash Flow | -162.14 Million | 121.2 Million | 100.39 Million | 115.47 Million | 37.74 Million | 54.46 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 49.53 Million | 231.11 Million | 132.57 Million | 240.29 Million | 78.73 Million | 126.03 Million |
| Depreciation & Amortization | 44.57 Million | 90.93 Million | 44.31 Million | 80.4 Million | 37.56 Million | 40.88 Million |
| Deferred income taxes | - | - | - | - | -2.05 Million | - |
| Stock-based compensation | 5.05 Million | 5.05 Million | - | 8.12 Million | 8.12 Million | - |
| Change in working capital | -260.74 Million | -235.53 Million | - | -40.33 Million | -15.16 Million | - |
| Other non-cash items | 181.15 Million | -25.44 Million | -162.53 Million | -45.56 Million | -81.12 Million | 47.87 Million |
| Investing Cash Flow | -161.77 Million | -318.14 Million | -156.37 Million | -82.29 Million | 125.26 Million | -207.56 Million |
| Investments in PPE | -70.7 Million | -196.07 Million | -113.09 Million | -121.71 Million | -43.61 Million | -71.58 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -1.76 Billion | - | -1.92 Billion | - | - |
| Sales/Maturities of investments | - | 1.62 Billion | - | 1.94 Billion | - | - |
| Other Investing Activities | -91.07 Million | 1.05 Million | -43.27 Million | 18.64 Million | 168.88 Million | -135.97 Million |
| Financing Cash Flow | -46.55 Million | -14.02 Million | 32.53 Million | -36.79 Million | -28.03 Million | -8.76 Million |
| Debt repayment | - | -53.54 Million | -27.16 Million | -10.71 Million | - | -7.61 Million |
| Dividends payments | -61.5 Million | -61.5 Million | - | -23.96 Million | -23.96 Million | - |
| Common Stock Repurchased | - | - | - | 10.71 Million | - | - |
| Common Stock Issuance | - | 8.93 Million | - | 57 Thousand | - | - |
| Other Financing Activities | 14.95 Million | 7.11 Million | 5.37 Million | -12.89 Million | -4.07 Million | -1.15 Million |
| Accounts receivables | 3.32 Million | 3.32 Million | - | -26.81 Million | -26.81 Million | - |
| Accounts payables | - | - | - | 26.81 Million | - | - |
| Inventory | -193.18 Million | -193.18 Million | - | 20.73 Million | 20.73 Million | - |
| Other working capital | -70.88 Million | -70.88 Million | - | -61.07 Million | -9.08 Million | - |
| Cash at beginning of period | 525.78 Million | 625.82 Million | 625.82 Million | 475.6 Million | 484.94 Million | 475.6 Million |
| Cash at end of period | 525.78 Million | 331.21 Million | 525.78 Million | 625.82 Million | 625.82 Million | 484.94 Million |
| Capital Expenditure | -70.7 Million | -196.07 Million | -113.09 Million | -121.71 Million | -43.61 Million | -71.58 Million |
| Effect of forex changes on cash | -5.81 Million | 3.62 Million | 9.43 Million | 26.39 Million | 15.52 Million | 10.87 Million |
| Net cash flow / Change in cash | - | -294.61 Million | -100.04 Million | 150.22 Million | 140.88 Million | 9.33 Million |
| Free Cash Flow | -51.12 Million | -162.14 Million | -98.73 Million | 121.2 Million | -15.48 Million | 143.2 Million |
0097
FISCHER
CCHI
TRIN
1721
RBNK